| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 1114 |
| 1 | ADALIMUMAB | 956 |
| 2 | PREDNISONE | 929 |
| 3 | METHOTREXATE | 906 |
| 4 | ETANERCEPT | 710 |
| 5 | PREDNISOLONE | 634 |
| 6 | PREDNISOLONE ORAL | 634 |
| 7 | PREDNISOLONE ORAL SOLUTION | 634 |
| 8 | RITUXIMAB | 496 |
| 9 | FOLIC ACID | 360 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETRANACOGENE DEZAPARVOVEC | 7 | 0.1186 |
| 1 | NEOSTIGMINE METHYLSULFATE | 9 | 0.0211 |
| 2 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 5 | 0.0117 |
| 3 | PENTOSTATIN | 9 | 0.0086 |
| 4 | BRODALUMAB | 15 | 0.0075 |
| 5 | DINUTUXIMAB | 6 | 0.0072 |
| 6 | RITUXIMAB-PVVR | 30 | 0.0059 |
| 7 | CALCIUM CHLORIDE INJECTION | 17 | 0.0056 |
| 8 | TAZAROTENE | 6 | 0.0051 |
| 9 | CIDOFOVIR ANHYDROUS | 7 | 0.0050 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 2115 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 1298 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 902 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 864 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 754 |
| 5 | Vitamin C [EPC] | 464 |
| 6 | Kinase Inhibitor [EPC] | 422 |
| 7 | Proton Pump Inhibitor [EPC] | 406 |
| 8 | Vitamin B12 [EPC] | 405 |
| 9 | Vitamin D [EPC] | 387 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 15 | 0.0075 |
| 1 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 6 | 0.0057 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 14 | 0.0045 |
| 3 | Neonatal Fc Receptor Blocker [EPC] | 20 | 0.0038 |
| 4 | Oxytocic [EPC] | 11 | 0.0037 |
| 5 | Rifamycin Antimycobacterial [EPC] | 12 | 0.0035 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 65 | 0.0034 |
| 7 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 41 | 0.0031 |
| 8 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 7 | 0.0029 |
| 9 | Purine Antimetabolite [EPC] | 256 | 0.0026 |